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Abstract. Azulenequinone derivatives have been reported to
display a broad spectrum of biological activities, but study at
the cellular level has been limited. The effect of twenty-seven
azulenequinone derivatives on nitric oxide (NO) production by
mouse macrophage-like cells Raw 264.7 was investigated in this
study. All of these compounds failed to stimulate the Raw 264.7
cells to produce detectable amounts of NO, but did inhibit NO
production by lipopolysaccharide (LPS)-activated Raw 264.7
cells to varying extents. Compounds [7, 8, 9, 13, 16, 25, 27],
which showed lesser cytotoxic activity (CC50=425, 381, 482,
179, 119, 235, 225 ÌM, respectively), inhibited NO production
to the greatest extent [selectivity index (SI)= 15.4, 26.2, 3.9,
21.6, 3.1, 6.0, 8.4, respectively]. Western blot and RT-PCR
analyses demonstrated that the most active derivatives, 3-
morpholino-1,5-azulenequinone [8] and 3,7-dibromo-1,5-
azulenequinone [13], significantly reduced both the
intracellular concentration of iNOS protein and the expression
of iNOS mRNA. ESR spectroscopy showed that compounds [8,
13] weakly scavenged NO produced by NOC-7, possibly via
their general reducing activity. These data suggest that the
inhibitory effect of NO production by compounds [8, 13] might
be generated mostly via the inhibition of iNOS expression,
rather than the radical-mediated mechanism.
Azulene derivatives (1-4) have shown several biological
activities, including antibacterial activity (5), anti-ulcer activity
(6), relaxant activity (7), inhibition of thromboxane A2-
induced vasoconstriction and thrombosis (8), acute toxicity
and local anesthetic activity (9), and possible
chemotherapeutic activity for mucous membrane diseases (10,
11). We have recently reported that methyl 7-isopropyl-2-
methoxyazulene-1-carboxylate (12) and 5-aminotropolone
(13) induced tumor-specific cytotoxicity and apoptotic cell
death (characterized by internucleosomal DNA fragmentation
and caspase 3 activation) in HL-60 cells, without (12) or with
(13) involvement of the radical-mediated oxidation
mechanism, and that 1,3-difluoroazulene (14) and 2,4-
dibromo-7-methoxytropone (15) inhibited nitric oxide (NO)
production by LPS-activated mouse macrophage-like Raw
264.7 cells, via partial inhibition of inducible NO synthase
(iNOS) expression without involvement of NO radical
scavenging activity.
Azulenequinone is a nonbenzenoid aromatic quinone (16,
17) and is also an isomer of naphthoquinone. Naphtho-
quinones have shown antifungal, antibiotic, antimalarial and
antitumor activity (18). However, the effects of
azulenequinone derivatives on cellular function have not been
investigated in detail. We recently found that 3-(3-
guaiazulenyl)-1,5-azulenequinone [12] and 7-isopropyl-3-(4-
methylanilino)-2-methyl-1,5-azulenequinone [24] (Figure 1)
showed relatively higher tumor-specific cytotoxicity and
induced apoptosis in human promyelocytic leukemia HL-60
and oral squamous cell carcinoma HSC-2 cells, possibly via
the activation of both mitochondria-independent (extrinsic)
and -dependent (intrinsic) pathways (19). We investigated
here whether twenty-seven azulenequinone derivatives (Figure
1), such as azulenes (14) and tropolons (15), inhibit the nitric
oxide (NO) production by unstimulated- and lipolysaccharide
(LPS)-stimulated mouse macrophage-like Raw 264.7 cells.
The NO concentration is determined by the intracellular
concentration and activity of iNOS protein, and quenching of
NO radical, which interacts with superoxide anion (O2
–).
Therefore, we also investigated whether azulenequinone
derivatives affect the expression of iNOS protein and mRNA
4157
Correspondence to: Hidetsugu Wakabayashi, Faculty of Science,
Josai University, Sakado, Saitama 350-0295, Japan. Tel: (+81)049-
271-7959, Fax: (+81)049-271-7985, e-mail: hwaka@josai.ac.jp
Key Words: Azulenequinones, Raw 264.7 cells, NO, iNOS, ESR,
radicals.
ANTICANCER RESEARCH 25: 4157-4164 (2005)
Inhibition of LPS-stimulated NO Production in Mouse
Macrophage-like Cells by Azulenequinones
MASAYUKI NISHISHIRO1, SATOMI ARIKAWA1, HIDETSUGU WAKABAYASHI1, KEN HASHIMOTO2,
KAZUE SATOH2,3, KEIKO YOKOYAMA4, SENWA UNTEN4, HANZO KAKUTA4, 
TERUO KURIHARA1, NOBORU MOTOHASHI5 and HIROSHI SAKAGAMI2
1Faculty of Science, Josai University, Sakado, Saitama;
2Department of Dental Pharmacology, Meikai University School of Dentistry, Sakado, Saitama; 
3Department of Anatomy, School of Medicine, Showa University, Tokyo;
4Fujimi Bee House, Shiki, Saitama; 5Meiji Pharmaceutical University, Kiyose, Tokyo, Japan
0250-7005/2005 $2.00+.40
(by Western blot analysis and RT-PCR analyses) and scavenge
various radicals, such as NO [generated from 1-hydroxy-2-oxo-
3-(N-3-methyl-3-aminopropyl)-3-methyl-1-triazene (NOC-7, a
NO generator), in the presence of 2-(4-carboxyphenyl)-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide (carboxy-PTIO, a spin
trap agent)] and superoxide anion (O2
–) [generated by
hypoxanthine (HX) - xanthine oxidase (XOD) reaction in the
presence of 5,5-dimethyl-1-pyrroline-N-oxide (DMPO)], by
ESR spectroscopy.
Materials and Methods
Materials. The following chemicals and reagents were obtained from
the indicated companies: Dulbecco's modified Eagle medium
(DMEM), phenol red-free DMEM (Gibco BRL, Grand Island, NY,
USA); fetal bovine serum (FBS) (JRH Bioscience, Lenexa, KS,
USA); 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), dimethyl sulfoxide (DMSO) (Wako Pure Chem. Ind., Ltd.,
Osaka, Japan); HX, XOD, diethylenetriaminepentaacetic acid
(DETAPAC), phenylmethylsulfonyl fluoride (PMSF) (Sigma Chem.
Co., St. Louis, MO, USA); DMPO, carboxy-PTIO, NOC-7,
superoxide dismutase (SOD) from bovine erythrocytes (Dojin,
Kumamoto, Japan).
Synthesis of azulenequinone derivatives. Azulenequinone derivatives
were synthesized, according to the following published reports: 1,5-
azulenequinone [1] (20-25), 3-chloro-1,5-azulenequinone [2] (23,
25, 26), 3-bromo-1,5-azulenequinone [3] (23, 25, 27), 3-iodo-1,5-
azulenequinone [4] (23, 25, 26), 3-phenoxy-1,5-azulenequinone [5]
(23, 28), 3-(4-nitrophenoxy)-1,5-azulenequinone [6] (23, 28), 3-
(N,N-dimethylamino)-1,5-azulenequinone [7] (23, 28), 3-
morpholino-1,5-azulenequinone [8] (23, 28) 3-(2-
hydroxyethylamino)-1,5-azulenequinone [9] (23, 28) 3-(4-
methoxyanilino)-1,5-azulenequinone [10] (23, 28), 3-(1-azulenyl)-
1,5-azulenequinone [11] (23, 28), 3-(3-guaiazulenyl)-1,5-
azulenequinone [12] (23, 28), 3,7-dibromo-1,5-azulenequinone [13]
(23, 25, 27), 3-bromo-1,7-azulenequinone [14] (23, 25, 27), 3-iodo-
1,7-azulenequinone [15] (23, 25, 26), 3-(4-nitrophenoxy)-1,7-
azulenequinone [16] (23, 28), 3-(N,N-dimethylamino)-1,7-
azulenequinone [17] (23, 28), 3-morpholino-1,7-azulenequinone
[18] (23, 28), 3-(4-methoxyanilino)-1,7-azulenequinone [19] (23,
28), 3-bromo-2-methyl-1,5-azulenequinone [20] (23, 24), 3-bromo-
2-methoxy-1,5-azulenequinone [21] (23, 29), 3-bromo-4,6,8-
trimethyl-1,5-azulenequinone [22] (23, 30), 3-(N,N-
dimethylamino)-5-isopropyl-1,7-azulenequinone [23] (23), 7-
isopropyl-3-(4-methylanilino)-2-methyl-1,5-azulenequinone [24]
(23), 7-isopropyl-3-(N,N-dimethylamino)-1,5-azulenequinone [25]
(23), 7-isopropyl-3-morpholino-1,5-azulenequinone [26] (23, 31), 3-
(2-hydroxyethylamino)-7-isopropyl-1,5-azulenequinone [27] (23,31).
Cell culture. Mouse macrophage-like Raw 264.7 cells were cultured
in DMEM supplemented with 10% heat-inactivated FBS under a
humidified 5% CO2 atmosphere (14, 15).
Assay for cytotoxic activity. The cytotoxic activity of azulenes was
determined by the MTT method, and expressed as absorbance at
540 nm of the MTT-stained cells. The 50% cytotoxic concentration
(CC50) was determined from the dose-response curve (14, 15).
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Figure 1. Structure of azulenequinones used in this study.
Assay for NO concentration. Near-confluent Raw 264.7 cells were
incubated for 24 h with each test sample in phenol red-free DMEM
supplemented with 10% FBS, and the NO production by Raw 264.7
cells was quantified by Greiss reagent, using the standard curve of
NO2
–. To eliminate the interaction between the sample and Greiss
reagent, the NO concentration was measured in the culture medium
without the cells, and this value was subtracted from that obtained
with the cells. The concentration that inhibited the LPS-stimulated
NO production by 50% (50% inhibitory concentration: IC50) was
determined from the dose-response curve (13, 14). The efficacy of
inhibition of NO production was estimated by the selectivity index
SI, which was calculated by the following equation:
SI=CC50/IC50.
Western blotting. The cell pellets were lysed with 100 ÌL of lysis buffer
(10 mM Tris-HCl, pH 7.6, 1% Triton X-100, 150 mM NaCl, 5 mM
EDTA and 2 mM PMSF) for 10 min in ice water, and then incubated
for 50 min at 4ÆC with RT-5 ROTATOR (Titec, Saitama, Japan). The
cell lysates were centrifuged at 16,000 x g for 20 min at 4ÆC to remove
the insoluble materials and the supernatant was collected. The protein
concentrations of the supernatant were measured by Protein Assay Kit
(Bio Rad, Hercules, CA, USA). An equal amount of the protein from
cell lysates (10 Ìg) was mixed with 2 x sodium dodecyl sulfate (SDS)-
sample buffer (0.1 M Tris-HCl, pH 6.8, 20% glycerol, 4% SDS, 0.01%
bromphenol blue, 1.2% 2-mercaptoethanol), boiled for 
10 min, applied to the SDS-7% polyacrylamide gel electrophoresis,
and then transferred to polyvinylidene difluoride (PVDF) membrane.
The membranes were blocked with 5% skim milk in phosphate-
buffered saline [PBS(-)] plus 0.05% Tween 20 for 
90 min and incubated with anti-iNOS antibody (1:1,000, Santa Cruz
Biotechnology, Delaware, CA, USA) for 90 min at room temperature
or overnight at 4ÆC, and then incubated with horseradish peroxidase-
conjugated anti-rabbit IgG for 1 h at room temperature. Immunoblots
were detected by Western Lightningì Chemiluminescence Reagent
Plus (Perkin Elmer Life Sciences, Boston, MA, USA).
Assay for mRNA expression. Total RNA was isolated by the
PURESCRIPT RNA Isolation kit (Gentra systems) protocol. Raw
264.7 cells were lysed in 300 ÌL cell lysis solution, and then 100 ÌL
Protein-DNA precipitation solution was added. Cell lysates were
centrifuged at 15,000 x g for 3 min. To the supernatant, 300 ÌL
isopropanol was added. After centrifugation at 15,000 x g for 3 min,
the pellet was washed in 300 ÌL 75% ethanol. After centrifugation
at 15,000 x g for 1 min, the pellet was air dried for 15 min and
dissolved in DEPC-treated H2O. A reverse transcriptase reaction
(RT) was performed with 1.0 Ìg of total RNA, using the Rever Tra
Ace (Toyobo Co., Ltd.), using oligo (dT)20 primer (14, 15). Single
strand cDNA, obtained by RT reaction, was amplified, using the
KOD plus (Toyobo Co., Ltd), using iNOS specific primers (5’-
CCCTTCCGAAGTTTCTGGCAGCAGC-3’ and 5’-
GGCTGTCAGAGCCTCGTGGCTTTGG-3’) and ‚-actin specific
primers (5'- GAGGCCCAGAGCAAGAGAGG-3', 5'-TACATGG
CTGGGGTGTTGAA-3'), according to the protocol. The RT-PCR
products were applied to 2% agarose gel, and the ethidium
bromide-stained gel was then photographed under UV light.
Radical scavenging activity. The radical intensity of azulenequinones
was determined at 25ÆC, using ESR spectroscopy (JEOL JES
REIX, X-band, 100 kHz modulation frequency) (19). For
determination of O2– produced by HX and XOD reactions (total
volume: 200 ÌL) [2 mM HX in 0.1 M phosphate buffer (pH 7.4)
(PB) 50 ÌL, 0.5 mM DETAPAC 20 ÌL, 8% DMPO 30 ÌL, sample
(in DMSO) 40 ÌL, H2O or SOD 30 ÌL, XOD (0.5 U/mL in PB) 
30 ÌL], the following instrument settings were used: center field,
336.0±5.0 mT; microwave power, 8 mW; modulation amplitude,
0.1 mT; gain, 400; time constant, 0.1 s; scanning time, 2 min (13-
15). The O2– scavenging activity was expressed as SOD units/mg
sample, by calibration with the standard curve of erythrocyte SOD.
The radical intensity of NO, produced from the reaction
mixture of 20 ÌM carboxy-PTIO and 80 ÌM NOC-7, was
determined in 0.1 M phosphate buffer, pH 7.4 in the presence of
30% DMSO. The microwave power and gain were changed to 
5 mW and 125, respectively. When NOC-7 (NO generator) and
carboxy-PTIO (spin trapping agent) were mixed, NO was oxidized
to NO2, and carboxy-PTIO was reduced to carboxy-PTI, which
produces seven-line signals. The NO radical intensity was defined
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Figure 2. Azulenequinones inhibited NO production by LPS-stimulated Raw
264.7 cells. Near-confluent Raw 264.7 cells were incubated for 24 h with the
indicated concentrations of 3-morpholino-1,5-azulenequinone [8] (A) or 3,7-
dibromo-1,5-azulenequinone [13] (B), in the absence (●, ■) or presence
(●, ■) of 100 ng/mL LPS in phenol red-free DMEM supplemented with
10% FBS, and then the viable cell number (●, ●) and extracellular
concentration of NO (■, ■) were determined by MTT assay and Griess
reagent, respectively. Each value represents the mean from 4 assays.
as the ratio of signal intensity of the first peak of carboxy-PTI to
that of MnO (14, 15).
Results
Relationship between cytotoxicity and inhibition of LPS-
stimulated NO production. LPS (100 ng/mL) treatment
enhanced the NO production by Raw 264.7 cells, from the
background level (<1 ÌM) to 20-25 ÌM (Figure 2). On the
other hand, all azulenequinone derivatives alone failed to
stimulate the Raw 264.7 cells to produce any detectable
amount of NO (data not shown).
We first investigated the cytotoxic activity of twenty-seven
azulenequinone derivatives against Raw 264.7 cells,
determined without LPS (Table I). Compound [21] showed
the highest cytotoxicity (CC50= 6 ÌM), followed by [1]
(CC50= 9 ÌM) > [5] (CC50=11 ÌM) > [20] (CC50= 21 ÌM)
> [12] (CC50= 27 ÌM) > [11] (CC50= 28 ÌM) > [4]
(CC50= 42 ÌM) > [6] (CC50= 44 ÌM) > [15, 26] (CC50=
46 ÌM) > [22] (CC50= 57 ÌM). These compounds inhibited
NO production by LPS-activated Raw 264.7 cells to varying
extents (SI=1.8, 2.8, 2.7, 2.8, 11.4, 12.6, 4.6, 2.7, 3.6, 17.1
and 2.4, respectively) (mean SI value=5.9±5.3).
Compounds [7, 8, 9, 13, 16, 25, 27], which showed lesser
cytotoxic activity (CC50=425, 381, 482, 179, 119, 235, 225
ÌM, respectively), inhibited NO production to the greatest
extent (SI= 15.4, 26.2, 3.9, 21.6, 3.1, 6.0 and 8.4,
respectively) (mean SI value=12.1±9.1). Compounds [2, 3,
14, 17, 18, 19, 23], which were the least cytotoxic
(CC50>500 ÌM), inhibited NO production to a lower extent
(SI=4.6, 8.6, 10.9, 8.0, 16.0, 3.0, 3.9, respectively) (mean SI
value=7.9±4.6).
iNOS expression. Since 3-morpholino-1,5-azulenequinone [8]
and 3,7-dibromo-1,5-azulenequinone [13] most effectively
inhibited NO production by LPS-activated Raw 264.7 cells
(SI=26.2 and 21.6, respectively) (IC50=12 and 7.6 ÌM,
ANTICANCER RESEARCH 25: 4157-4164 (2005)
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Table I. Inhibition of NO production by LPS-stimulated Raw 264.7 cells
by azulenequinones.
Compound MW. CC50(ÌM) IC50 (ÌM) SI
(–)LPS (+)LPS (+)LPS
[1] 158.16 9 5 <2 >2.8
[2] 192.6 >500 >500 110 >4.6
[3] 237.05 >500 >500 58 >8.6
[4] 284.05 42 32 7 4.6
[5] 250.26 11 8 3 2.7
[6] 295.25 44 19 7 2.7
[7] 201.25 425 386 25 15.4
[8] 243.26 381 315 12 26.2
[9] 217.22 482 >500 129 >3.9
[10] 279.3 n.d.a n.d. 246 n.d.
[11] 284.31 28 25 <2 >12.6
[12] 354.45 27 22 <2 >11.4
[13] 315.95 179 165 8 21.6
[14] 237.05 >500 483 44 10.9
[15] 284.05 46 45 13 3.6
[16] 295.25 119 114 37 3.1
[17] 201.23 >500 >500 63 >8.0
[18] 243.26 >500 >500 31 >16.0
[19] 279.3 >500 >500 167 >3.0
[20] 251.08 21 17 6 2.8
[21] 267.08 6 4 2 1.8
[22] 279.13 57 48 20 2.4
[23] 243.3 >500 >500 129 >3.9
[24] 319.4 n.d. n.d. 169 n.d.
[25] 243.3 235 217 37 6.0
[26] 285.34 46 46 3 17.1
[27] 259.3 225 371 44 8.4
a: not determined.
Figure 3. Effect of 3-morpholino-1,5-azulenequinone [8] and 3,7-
dibromo-1,5-azulenequinone [13] on the intracellular concentration of
iNOS protein in Raw 264.7 cells. Raw 264.7 cells were incubated for 24 h
in the absence or presence of 100 ng/mL LPS with the indicated
concentrations of 3-morpholino-1,5-azulenequinone [8] (A) or 3,7-
dibromo-1,5-azulenequinone [13] (B). The cell lysate was applied to SDS-
PAGE, and iNOS protein was quantified by Western blot analysis,
followed by densitometry. The intracellular iNOS protein was expressed as
the ratio to that of actin protein. The iNOS protein concentration without
LPS was below the detection limit and, therefore omitted. Each value
represents the mean from three independent experiments.
respectively), we next investigated whether these
compounds reduce the intracellular concentration of iNOS,
using Western blot analysis. Unstimulated Raw 264.7 cells
expressed only background levels of iNOS protein, but,
upon stimulation with LPS, the cells began to express
detectable amount of iNOS protein. The LPS-induced iNOS
expression was dose-dependently inhibited by simultaneous
addition of 3-morpholino-1,5-azulenequinone [8] or 3,7-
dibromo-1,5-azulenequinone [13] (Figure 3). The IC50 for
iNOS protein expression after addition of [8] or [13] was 3.1
and 9.3 ÌM, respectively.
RT-PCR analysis demonstrated that unstimulated Raw
264.7 cells expressed a trace amount of iNOS mRNA, and
treatment of Raw 264.7 cells with either 3-morpholino-1,5-
azulenequinone [8] or 3,7-dibromo-1,5-azulenequinone [13]
dose-dependently reduced this endogenous iNOS mRNA
expression (Figure 4). The levels of iNOS mRNA were
significantly enhanced by LPS (100 ng/mL), and the LPS-
enhanced iNOS mRNA synthesis was also dose-dependently
reduced by these compounds [8, 13] (IC50=10.0 and >22.8,
respectively) (Figure 4).
Radical scavenging activity. ESR spectroscopy shows that
compounds [8, 13, 18] scavenged NO produced by NOC-7
(IC50=554-687 Ìg/mL), to an extent much lower than that
attained by gallic acid (a positive control) (IC50=2.4
Ìg/mL). All samples reduced the intensity of carboxy-PTI
by 50-80%, suggesting their general reducing activity.
Therefore, the exact NO scavenging activity may be slightly
higher than that expressed in Table II.
Compound [13] potently scavenged O2
– generated by the
HX-XOD reaction (145 SOD unit/mg), but to a much lower
extent than that attained by gallic acid (6125 SOD unit/mg).
On the other hand, [8, 18, 26] (0.8, 2.0 and 1.9 SOD
unit/mg, respectively) were much less active (Table II).
Discussion
The present study demonstrated that azulenequinones
generally showed higher cytotoxicity and SI values than
azulenes (14). The parent compound, 1,5-azulenequinone
[1], showed relatively higher cytotoxicity and lower
selectivity of the inhibition of LPS-stimulated NO
production by Raw 264.7 cells (CC50=9 ÌM; SI=2.8).
Similarly, 3-(4-nitrophenoxy)-1,5-azulenequinone [6] and 3-
bromo-2-methoxy-1,5-azulenequinone [21] showed relatively
higher cytotoxicity and low selectivity (CC50=44 and 6 ÌM,
respectively; SI=2.7 and 1.8, respectively).
1,5-Azulenequinones showed comparable SI values with
the corresponding 1,7-azulenequinones: 3-bromo-1,5-
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Figure 4. Effect of 3-morpholino-1,5-azulenequinone [8] and 3,7-
dibromo-1,5-azulenequinone [13] on LPS-stimulated iNOS mRNA
expression. Raw 264.7 cells were incubated for 24 h in the absence or
presence of 100 ng/mL LPS with the indicated concentrations of 3-
morpholino-1,5-azulenequinone [8] (A) or 3,7-dibromo-1,5-
azulenequinone [13] (B). RNA was then isolated, and the PT-PCR
product was applied to agarose gel electrophoresis and quantified by
densitometry. The expression of iNOS mRNA was expressed as the ratio to
that of ‚-actin mRNA. Each value represents the mean from three
independent experiments.
Table II. Radical scavenging activity of 3-morpholino-1,5-azulenequinone
[8] and 3,7-dibromo-1,5-azulenequinone [13], 3-morpholino-1,7-
azulenequinone [18] and 7-isopropyl-3-morpholino-1,5-azulenequinone
[26].
Compound Scavenging activity against
NOa) (IC50: Ìg/mL) O2–(SOD unit/mg)
[8] 554.0 0.8
[13] 609.0 145.0
[18] 687.0 2.0
[26] No activityb) 1.9
Gallic acid 2.4 6125.0
a)determined at 3 min after mixing.
b)NO scavenging activity was not detected.
azulenequinone [3] (SI=8.6) and 3-bromo-1,7-azulene-
quinone [14] (SI=10.9); 3-iodo-1,5-azulenequinone [4]
(SI=4.6) and 3-iodo-1,7-azulenequinone [15] (SI=3.6); 3-
phenoxy-1,5-azulenequinone [5] (SI=2.7) and 3-(4-
nitrophenoxy)-1,7-azulenequinone [16] (SI=3.1); 3-(N,N-
dimethylamino)-1,5-azulenequinone [7] (SI=15.4) and 3-
(N,N-dimethylamino)-1,7-azulenequinone [17] (SI=8.0); 3-
morpholino-1,5-azulenequinone [8] (SI=26.2) and 3-
morpholino-1,7-azulenequinone [18] (SI=16.0); 7-isopropyl-
3-(N,N-dimethylamino)-1,5-azulenequinone [25] (SI=6.0)
and 3-(N,N-dimethylamino)-5-isopropyl-1,7-azulenequinone
[23] (SI=3.9).
Azulenequinones with the substituted azulene ring, such
as 3-(1-azulenyl)-1,5-azulenequinone [11] and 3-(3-
guaiazulenyl)-1,5-azulenequinone [12], showed higher
cytotoxicity and SI values (CC50=28 and 27 ÌM,
respectively; SI=12.6 and 11.4, respectively).
In general, amino-derivatives such as 3-(N,N-
dimethylamino)-1,5-azulenequinone [7], 3-morpholino-1,5-
azulenequinone [8], 3-(N,N-dimethylamino)-1,7-azulene-
quinone [17], 3-morpholino-1,7-azulenequinone [18], 7-
isopropyl-3-morpholino-1,5-azulenequinone [26] and 3-(2-
hydroxyethylamino)-7-isopropyl-1,5-azulenequinone [27]
showed higher SI values (SI=15.4, 26.2, 8.0, 16.0, 17.1 and
8.4, respectively).
Among hologenated derivatives, 3-bromo-1,5-azulene-
quinone [3], 3,7-dibromo-1,5-azulenequinone [13] and 3-
bromo-1,7-azulenequinone [14] showed the relatively higher
SI values (SI=8.6, 21.6 and 10.9, respectively).
Addition of an alkyl group consistently reduced the SI
value of the parent compound: 3-bromo-1,5-azulenequinone
[3] (SI=8.6) and 3-bromo-2-methyl-1,5-azulenequinone [20]
(SI=2.8); 3-(N,N-dimethylamino)-1,5-azulenequinone [7]
(SI=15.4) and 7-isopropyl-3-(N,N-dimethylamino)-1,5-
azulenequinone [25] (SI=6.0); 3-morpholino-1,5-azulene-
quinone [8] (SI=26.2) and 7-isopropyl-3-morpholino-1,5-
azulenequinone [26] (SI=17.1).
In general, methoxy- and phenoxy-derivatives showed
relatively higher cytotoxicity but lower SI values: 3-phenoxy-
1,5-azulenequinone [5] (CC50=11 ÌM, SI=2.7), 3-(4-
nitrophenoxy)-1,5-azulenequinone [6] (CC50=44 ÌM,
SI=2.7), 3-(4-nitrophenoxy)-1,7-azulenequinone [16]
(CC50=119 ÌM, SI=3.1) and 3-bromo-2-methoxy-1,5-
azulenequinone [21] (CC50=6 ÌM, SI=1.8).
The present study demonstrated that the most active
compounds [8, 13] inhibited NO production by activated
macrophages mainly via the inhibition of iNOS protein
expression. Compound [8] almost completely inhibited
iNOS mRNA expression, whereas [13] partially inhibited
the iNOS mRNA expression, by an, as yet, unknown
mechanism. We found that [13] not only scavenged the O2
–
radical (Table II), but also produced the carbon radical
(data not shown), suggesting the bimodal action of this
compound, i.e. antioxidant action at lower concentration
and pro-oxidant action at higher concentrations. The
present study suggests that compounds [8, 13] may modify
the function of macrophages. Further studies are required
to demonstrate the anti-inflammatory action of these
compounds.
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